159 results on '"DʼAvolio A"'
Search Results
2. Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert Panel
3. Rebuttal letter: Different underlying mechanism might explain the absence of a significant difference in AUC of linezolid for different ABCB1 genotypes
4. LC-MS/MS-Based Quantification of 9 Antiepileptic Drugs From a Dried Sample Spot Device
5. Different Underlying Mechanism Might Explain the Absence of a Significant Difference in Area Under the Concentration–Time Curve of Linezolid for Different ABCB1 Genotypes
6. Shifting management in healthcare: An integrative review of design thinking
7. A Common mdr1 Gene Polymorphism is Associated With Changes in Linezolid Clearance
8. Clinical relevance of deferasirox trough levels in β‐thalassemia patients
9. Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children
10. Cannabinoids concentration variability in cannabis olive oil galenic preparations
11. Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma
12. Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children
13. Treatment with direct‐acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study
14. Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro‐resected patient
15. The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin‐induced anaemia in chronic hepatitis C Egyptian patients
16. Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients
17. Sequential therapy with entecavir and peginterferon alpha in chronic hepatitis B: for many but not for all?
18. Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study
19. Impact of Nutrition Education with and Without Diet Coaching on Dietary Protein Intakes Of Caregivers Their Family Members With Dementia
20. UPLC–MS/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells☆
21. UPLC–MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients
22. A LC–MS method to quantify tenofovir urinary concentrations in treated patients☆
23. A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs
24. Pharmacokinetics of high dosage of linezolid in two morbidly obese patients
25. Influence of single-nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness
26. Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross-sectional study in rural Burundi
27. SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir
28. In Vitro Stability Evaluation of Different Pharmaceutical Products Containing Meropenem
29. Treatment optimization of naïve HCV-1 patients using IL28B, RVR and fibrosis stage
30. Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon
31. An UPLC–MS/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells
32. Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots
33. Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients
34. Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms
35. Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E
36. Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients
37. Voriconazole and atazanavir: a CYP2C19-dependent manageable drug–drug interaction
38. Pharmacokinetics of the co-administration of boceprevir and St Johnʼs wort to male and female healthy volunteers
39. Low-density lipoprotein and ritonavir: an interaction between antiretrovirals and lipids mediated by P-glycoprotein
40. Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection
41. Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir
42. Development and validation of a useful UPLC–MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients☆
43. How effective are the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring?
44. High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis
45. Personalizing HIV Therapeutics in Resource-Limited Rural Communities: Lessons Learned From the Use of New Tools in Africa
46. Early virological failure with cabotegravir/rilpivirine.
47. Shiro, Marta; Charaudeau, Patrick y Granato, Luisa (eds.). (2012). Los géneros discursivos desde múltiples perspectivas: teorías y análisis
48. CASSANY, DANIEL (2006) Tras las líneas. Sobre la lectura contemporánea
49. Intraductal papillary mucinous neoplasm of the pancreas. Personal series and synthetic review
50. Barriers to Primary Care: Perceptions of Older Adults Utilizing the ED for Nonurgent Visits
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.